PHARMAGNOSE BIOTECHNOLOGY S.A. Chalkida , Greece

Company Website: http://pharmagnose.com/

Company Email: info@pharmagnose.com

Employees: 16

Funding State: Bootstrapped


Industries

  • Life Sciences (MedTech, HealthTech, BioTech)

Technology

  • Other

Business Model

  • B2B

Revenue Model

  • Other

Funding Sources

  • Self

About

PharmaGnose provides state-of-the-art processes in the field of bioactive natural products, offering R&D solutions in terms of products and services: development, analysis and production of plant extracts, production of high added-value products from agricultural waste, utilization of Greek plant biodiversity, isolation and chemical characterization of natural products of high purity, metabolomic studies, identification and quantification of biomarkers and in silico studies.


Solution & Product

During the last decades there has been an incredible shift towards the exploitation of natural resources for the discovery of agents that can benefit human health and healthy living. Natural products continuously gain the attention of cosmetic, food and pharmaceutical industries, thus there is a great opportunity for Greece to exploit its plant biodiversity and know-how. Since 2013, PharmaGnose has been established as a reliable state-of-the-art provider in the field of bioactive natural products. It invests in the development of patentable plant extracts with novel and promising properties and in the development and validation of state-of-the-art analytical methods (profiling, fingerprinting, quality control, metabolism studies, biomarker recognition) by applying and combining edge technologies. PharmaGnose is promoting and applying the use of "green", environmentally friendly techniques in all the steps of research, extraction and isolation, aiming to produce unique extracts from the Greek biodiversity, fully characterized in terms of chemical content.


Innovation & Scalability

PharmaGnose implements new or significantly improved goods, services, processes in the value chain of natural products. Our core expertise is based on the knowledge of natural substances and on a multidisciplinary technological platform to leverage this knowledge in active molecules or ingredients discovery for the pharmaceutical, cosmetic and agro-food industries. Since 2016, we have a steady increase in turnover by 40% annually.


Traction & achievements

PharmaGnose has gained the trust of several major international and national industries in the cosmetic, food and pharmaceutical fields, through the collaboration in R&D projects and the procurement of plants extracts/pure compounds. Strategic collaborations are currently elaborated with large companies abroad at the level of assigning integrated research projects (e.g. L'Oreal). Products coming from characteristic plants of the Greek flora as well as extracts from agricultural byproducts, have triggered the interest of cosmetics and food companies. PharmaGnose actively participates in funded research grants, being currently involved in 17 national projects and 2 European, in collaboration with Universities and Research Institutes.


Team & Why Us

The team consists of 16 people, specifically, 1 manager, 3 team leaders and 12 researchers holding Msc degrees (pharmacists, chemists, engineers, agriculturists).


Funding Needs

During 2021 PharmaGnose is planning to raise 4-5m €, to expand the production facilities.


ONE LINER

Spin-off company of the UoA specializing in high-end natural products research and production


TEAM


FUNDING

2021 - Pre Seed, Grant EUR 100, GSRT - Elevating Greek Startups against COVID 19

PATENTS

International Patent - Pending PCT/EP2020/083897

AWARDS


INCUBATIONS/ACCELERATIONS


Jobs


Perks